Your browser doesn't support javascript.
loading
Tetracyclines Enhance Anti-tumor T-Cell Responses Induced by a Bispecific T-Cell Engager.
Noguchi, Yuki; Yamamoto, Yoko; Iwahori, Kota; Matsumoto, Mitsunobu; Hirata, Michinari; Okuyama, Hiroomi; Shintani, Yasushi; Kumanogoh, Atsushi; Wada, Hisashi.
Afiliación
  • Noguchi Y; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University.
  • Yamamoto Y; Department of Pediatric Surgery, Graduate School of Medicine, Osaka University.
  • Iwahori K; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University.
  • Matsumoto M; Department of General Thoracic Surgery, Graduate School of Medicine, Osaka University.
  • Hirata M; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University.
  • Okuyama H; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University.
  • Shintani Y; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University.
  • Kumanogoh A; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University.
  • Wada H; Shionogi & Co., Ltd.
Biol Pharm Bull ; 45(4): 429-437, 2022.
Article en En | MEDLINE | ID: mdl-35370267
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Biol Pharm Bull Asunto de la revista: BIOQUIMICA / FARMACOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Biol Pharm Bull Asunto de la revista: BIOQUIMICA / FARMACOLOGIA Año: 2022 Tipo del documento: Article